Skip to content

Medical-device intelligence

LON: System, Test, Automated, Antimicrobial Susceptibility, Short Incubation

FDA product code LON: System, Test, Automated, Antimicrobial Susceptibility, Short Incubation. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
LON
FDA device name
System, Test, Automated, Antimicrobial Susceptibility, Short Incubation
Device class
2
Regulation number
866.1645
Medical specialty
Microbiology
Review panel
MI

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

293 clearance records and 240 recall records in the covered releases, across 22 source company names and 1 product codes. Dated history runs from Aug 1, 1986 to Nov 4, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202610
April 202610
May 202600
June 202603
July 202601
August 202602
September 202610
October 202610

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

533 matching records
Device / recordCompany in FDA recordSourceSource date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM- CEFUROXIME GRAM NEGATIVEK033362 · LONBecton, Dickinson & CO510(k)Apr 9, 2004FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - TRIMETHOPRIM-SULFAMETHOXAZOLE 0.5/9.5 - 16/304 UG/MLK033907 · LONBecton, Dickinson & CO510(k)Apr 9, 2004FDA decision date
MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH CEPHALOTHIN (0.5-32 UG/ML)K031601 · LONDade Behring, Inc.510(k)Apr 2, 2004FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEMK040099 · LONBecton, Dickinson & CO510(k)Mar 19, 2004FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM -- AMPICILLIN -- GRAM POSITIVEK040106 · LONBecton, Dickinson & CO510(k)Mar 11, 2004FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-CEFEPIME (GN) 0.5-65 UG/MLK032675 · LONBecton, Dickinson & CO510(k)Mar 1, 2004FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-LINEZOLID-GRAM POSITIVEK040006 · LONBecton, Dickinson & CO510(k)Feb 27, 2004FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - ERYTHROMYCIN 0.0625-8 UG/MLK033784 · LONBecton, Dickinson & CO510(k)Feb 3, 2004FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM FOR USE WITH THE ANTIMICROBIAL AGENT CHLORAMPHENICOL 1-32 UG/ML GRAM POSITIVEK033889 · LONBecton, Dickinson & CO510(k)Feb 3, 2004FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - TICARCILLIN/CLAVULANATE-GRAM NEGATIVEK033557 · LONBecton, Dickinson & CO510(k)Jan 14, 2004FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFTAZIDIME 0.5-64 UG/ML-GRAM-NEGATIVE ID/AST OR AST ONLY PHOENIX PANELSK033560 · LONBecton, Dickinson & CO510(k)Jan 14, 2004FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - AZTREONAM 0.5-64 UG/ML-GRAM-NEGATIVE ID/AST OR AST ONLY PHOENIX PANELSK033558 · LONBecton, Dickinson & CO510(k)Dec 19, 2003FDA decision date
MYCOPLASMA IGGK033064 · LONTrinity Biotech USA510(k)Nov 26, 2003FDA decision date
MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH AMPICILLIN (0.25-128 UG/ML)K033482 · LONDade Behring, Inc.510(k)Nov 26, 2003FDA decision date
VITEK 2 GRAM NEGATIVE MOXIFLOXACINK032861 · LONbioMerieux, Inc.510(k)Nov 12, 2003FDA decision date
VITEK 2 GRAM NEGATIVE GATIFLOXACINK032788 · LONbioMerieux, Inc.510(k)Nov 4, 2003FDA decision date
VITEK GRAM NEGATIVE GATIFLOXACINK032711 · LONbioMerieux, Inc.510(k)Oct 31, 2003FDA decision date
VITEK 2 GRAM POSITIVE QUINUPRISTIN/DALFOPRISTINK032738 · LONbioMerieux, Inc.510(k)Oct 31, 2003FDA decision date
VITEK 2 GRAM POSITIVE LINEZOLIDK032766 · LONbioMerieux, Inc.510(k)Oct 31, 2003FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-CEFTRIAXONE 0.5-64 UG/MLK032655 · LONBecton, Dickinson & CO510(k)Oct 6, 2003FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-IMIPENEM 1-16 UG/ML GRAM-NEGATIVE ID/AST OR AST ONLY PHOENIX PANELSK032275 · LONBecton, Dickinson & CO510(k)Sep 29, 2003FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM,-AMPICILLIN 0.5.-32 UG/MLK032299 · LONBecton, Dickinson & CO510(k)Sep 22, 2003FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-CEFOXITIN-GRAM NEGATIVEK032567 · LONBecton, Dickinson & CO510(k)Sep 17, 2003FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM CEFOTAXIME 0.5-64 UG/MLK032153 · LONBd Diagnostic Systems510(k)Sep 11, 2003FDA decision date
VITEK 2 GRAM POSITIVE MOXIFLOXACINK032399 · LONbioMerieux, Inc.510(k)Sep 10, 2003FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗